Behavioral Pharmacology of THC and Beta-Myrcene (NCT05432284)

🧪 Interventions in This Study

• Placebo (DRUG)
• THC (DRUG)
• Beta-Myrcene (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Johns Hopkins School of Medicine Behavioral Pharmacology Research Unit — Baltimore, Maryland

📞 Contact the Study Coordinator

Phone: (410) 550-4036

Email: rvandrey@jhmi.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cannabis Use

• Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder — Aurora, Colorado
• Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use — Seattle, Washington
• Acute Effects of Cannabis on Cognition and Affect — Pullman, Washington
• Research Investigating Drug Effects-2 (RiDE-2) — Chicago, Illinois
• Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation — Palo Alto, California
• Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis — Lexington, Kentucky

Explore by condition: All Cannabis Use clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.